BETHLEHEM, Pa., April 28 /PRNewswire/ -- Particle Sciences, Inc. today announced the appointment of Robert W. Lee, Ph.D. to the position of Vice President, Pharmaceutical Development. Dr. Lee joins ...
BETHLEHEM, Pa., June 22, 2011 /PRNewswire/ -- In a recent announcement by Neurelis, a proprietary intranasal formulation of diazepam (NRL-1) achieved positive clinical results in a Phase I ...
BETHLEHEM, Pa., March 5, 2012 -- BETHLEHEM, Pa., March 5, 2012 /PRNewswire/ -- Particle Sciences, Inc. (PSI), a leading pharmaceutical CRO, and Lyotropic Therapeutics ...
BETHLEHEM, Pa., Jan. 3, 2012 /PRNewswire/ — Particle Sciences, a leading drug delivery CRO, has added a third computational module to its DOSE™ program. The DOSE™ program uses a combination of ...
Particle Sciences expects to have commercial manufacturing capabilities up and running at its Bethlehem, Pennsylvania, facility by the end of the year and intends to manufacture both sterile and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback